African meningitis

The 2009 West African meningitis outbreak resulted in several thousand infections and more than one hundred deaths.

MenAfriVac is available for widespread use in African meningitis belt countries.

The African meningitis belt is a region in sub-Saharan Africa where the rate of incidence of meningitis is very high.

The meningitis problem in that area is caused by a strain of meningitis called "meningitis A", which is present only in the African meningitis belt.

Meningitis outbreaks can occur throughout Chad, and are especially common in the south of the country, which lies within the African meningitis belt stretching from Senegal to Ethiopia.

Malaria and water-borne diseases to occur in CAR and meningitis outbreaks occur during the six-month dry season that starts in December, especially in the country's north, which lies within the African meningitis belt stretching from Senegal to Ethiopia.

The 2009-2010 West African meningitis outbreak is an epidemic of bacterial meningitis which has been occurring in Burkina Faso, Mali, Niger, and Nigeria since January 2009, an annual risk in the African meningitis belt.

The Project recently developed MenAfriVac, a low-cost conjugate A vaccine that is ready for widespread distribution to people between the ages of 1 and 29 in Burkina Faso, Mali, and Niger, three countries in the African meningitis belt with the highest rates of meningitis.